blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2789349

EP2789349 - Liquid preparation comprising pimobendan [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2018
Database last updated on 23.04.2024
FormerThe patent has been granted
Status updated on  04.08.2017
FormerGrant of patent is intended
Status updated on  18.04.2017
Most recent event   Tooltip05.06.2020Lapse of the patent in a contracting state
New state(s): PT		published on 08.07.2020  [2020/28]
Applicant(s)For all designated states
Boehringer Ingelheim Vetmedica GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2017/36]
Former [2014/42]For all designated states
Boehringer Ingelheim Vetmedica GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / Folger, Martin Andreas
Boehringer Ingelheim GmbH, Corporate Patents
Binger Str. 173
55216 Ingelheim am Rhein / DE
02 / Lehner, Stefan
Boehringer Ingelheim GmbH, Corporate Patents
Binger Str. 173
55216 Ingelheim am Rhein / DE
 [2015/19]
Former [2014/42]01 / FOLGER, Martin Andreas
Boehringer Ingelheim GmbH, Corporate Patents
Binger Str. 173
55216 INGELHEIM AM RHEIN / DE
02 / LEHNER, Stefan
Boehringer Ingelheim GmbH, Corporate Patents
Binger Str. 173
55216 INGELHEIM AM RHEIN / DE
Representative(s)Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2014/42]
Application number, filing date14171537.505.11.2007
[2014/42]
Priority number, dateEP2006012356707.11.2006         Original published format: EP 06123567
[2014/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2789349
Date:15.10.2014
Language:EN
[2014/42]
Type: B1 Patent specification 
No.:EP2789349
Date:06.09.2017
Language:EN
[2017/36]
Search report(s)(Supplementary) European search report - dispatched on:EP16.09.2014
ClassificationIPC:A61P21/04, A61K47/69
[2017/18]
CPC:
A61K31/501 (EP,BR,KR,US); A61K9/08 (EP,BR,KR,US); A61K47/40 (BR,US);
A61K47/50 (KR); A61K47/6951 (EP,BR,US); A61K9/0019 (EP,BR,US);
A61P1/00 (EP); A61P13/12 (EP); A61P21/04 (EP);
A61P43/00 (EP); A61P7/08 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); B82Y5/00 (EP,BR,US) (-)
Former IPC [2014/42]A61K47/48, A61K9/00, A61K9/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/22]
Former [2014/42]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesBA15.04.2015
HR15.04.2015
TitleGerman:Flüssiges Präparat mit Pimobendan[2014/42]
English:Liquid preparation comprising pimobendan[2014/42]
French:Préparation liquide comprenant du pimobendane[2014/42]
Examination procedure31.03.2015Amendment by applicant (claims and/or description)
15.04.2015Examination requested  [2015/22]
18.04.2017Communication of intention to grant the patent
25.07.2017Fee for grant paid
25.07.2017Fee for publishing/printing paid
25.07.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07822208.0  / EP2089060
Opposition(s)07.06.2018No opposition filed within time limit [2018/33]
Fees paidRenewal fee
06.10.2014Renewal fee patent year 03
06.10.2014Renewal fee patent year 04
06.10.2014Renewal fee patent year 05
06.10.2014Renewal fee patent year 06
06.10.2014Renewal fee patent year 07
01.12.2014Renewal fee patent year 08
30.11.2015Renewal fee patent year 09
30.11.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PT06.09.2017
SI06.09.2017
SK06.09.2017
LU05.11.2017
MT05.11.2017
BG06.12.2017
IS06.01.2018
[2020/28]
Former [2019/47]CY06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
SI06.09.2017
SK06.09.2017
LU05.11.2017
MT05.11.2017
BG06.12.2017
IS06.01.2018
Former [2018/43]EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
SI06.09.2017
SK06.09.2017
LU05.11.2017
MT05.11.2017
BG06.12.2017
IS06.01.2018
Former [2018/39]EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
SI06.09.2017
SK06.09.2017
LU05.11.2017
BG06.12.2017
IS06.01.2018
Former [2018/33]EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
SK06.09.2017
BG06.12.2017
IS06.01.2018
Former [2018/24]EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
SK06.09.2017
BG06.12.2017
IS06.01.2018
Former [2018/13]FI06.09.2017
LT06.09.2017
LV06.09.2017
BG06.12.2017
Former [2018/08]FI06.09.2017
LT06.09.2017
Former [2018/07]LT06.09.2017
Documents cited:Search[XY]WO2006022562  (BOMAC RESEARCH LTD [NZ], et al) [X] 1,2,4,5,8,11-13 * claims 1-6,19-24,29-31 * * page 15, line 15 - page 16, line 4 * * claim 28 * [Y] 1-15;
 [XY]EP0335545  (UNIV FLORIDA [US]) [X] 1,2,4,5,7,8,13 * claims 1,3,17,27,29,30,32 * * page 116, line 1 - line 3 * * page 16, line 37 - line 43 * [Y] 1-15;
 [YD]WO2005084647  (BOEHRINGER INGELHEIM VETMED [DE], et al) [YD] 1-15 * claims 1-12,16 *
 [XY]  - PIEL G ET AL, "DEVELOPMENT OF A PARENTERAL AND AN ORAL FORMULATION OF ALBENDAZOLE WITH CYCLODEXTRINS", SCIENCES TECHNIQUES ET PRATIQUES STP PHARMA PRATIQUES, PARIS, FR, (1999), vol. 9, no. 3, ISSN 1157-1497, pages 257 - 260, XP008076739 [X] 1,2,4-6,8,11-13 * abstract * * page 257, column 2, paragraph 2 * * Introduction * * page 259; table 1 * * page 259, column 2, paragraph 6 * [Y] 1-15
 [XY]  - BASSANI V L ET AL, "ENHANCED WATER-SOLUBILITY OF ALBENDAZOLE BY HYDROXYPROPYL-ss-CYCLODE XTRIN COMPLEXATION", JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, KLUWER, DORDRECHT, NL, (199603), vol. 25, no. 1-3, ISSN 0923-0750, pages 149 - 152, XP008076331 [X] 1,2,4,6,11-13 * abstract * * page 150; figure 2 * * page 150, paragraph 2 * * Introduction, conclusion * [Y] 1-15

DOI:   http://dx.doi.org/10.1007/BF01041557
by applicantWO2005092343
 EP0008391
 EP0439030
 WO2005008467
 WO8502767
 US3459731
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.